Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …

Neuroendocrine neoplasms constitute a diverse group of tumors that derive from the
sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary …

1. MATERIALS AND METHODS Data regarding the diagnosis, management, and follow‐up
of carcinoid syndrome (CS) and carcinoid heart disease (CHD) were identified by searches …

In recent decades, the incidence of neuroendocrine tumors (NETs) has steadily increased.
Due to the slow-growing nature of these tumors and the lack of early symptoms, most cases …

Simple Summary Peptide receptor radionuclide therapy (PRRT) is one of the treatment
options for locally advanced or metastatic gastroenteropancreatic (GEP) neuroendocrine …

The concept of using a targeting molecule labeled with a diagnostic radionuclide for using
positron emission tomography or single photon emission computed tomography imaging …

Carcinoid syndrome (CS) develops in patients with hormone‐producing neuroendocrine
neoplasms (NENs) when hormones reach a significant level in the systemic circulation. The …

Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

Carcinoid syndrome (CS) is a debilitating disease that affects approximately 20% of patients
with neuroendocrine neoplasms (NEN). Due to the increasing incidence and improved …

Gastro-enterohepatic neuroendocrine tumours (GEP-NETs) represent a rare and highly
heterogeneous entity with increasing incidence. Based on the results obtained from several …